Fischer Imaging

Fischer Imaging is a development-stage company with a rich history in medical imaging. The company, succeeds Fischer Imaging Corp, recognized for pioneering digital mammography and mammography-guided stereotactic biopsy. We are focused today on improving breast cancer imaging and diagnosis, aiming to enhance patient outcomes through advanced technologies. The company's flagship product, MammoCAT, is designed to address limitations in traditional breast imaging, such as pain, discomfort, poor performance in patients with dense breasts and excessive radiation, aligning with trends toward patient-centered care.